Industry Focus

AbbVie is developing new drugs to sidestep expiring patents on its best-seller, and a new FDA approval could be on deck at Clovis Oncology. Also, how Novartis plans to shake-up a multibillion dollar indication.

Direct download: 20170621_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST